AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 78 filers reported holding AVEO PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 29.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $9,000 | -18.2% | 16,272 | +30.3% | 0.00% | – |
| Q3 2016 | $11,000 | -52.2% | 12,492 | -48.3% | 0.00% | – |
| Q2 2016 | $23,000 | -81.0% | 24,154 | -81.6% | 0.00% | – |
| Q1 2016 | $121,000 | -32.0% | 131,494 | -6.7% | 0.00% | – |
| Q4 2015 | $178,000 | +9.2% | 140,888 | +4.5% | 0.00% | – |
| Q3 2015 | $163,000 | -32.4% | 134,846 | -2.6% | 0.00% | – |
| Q2 2015 | $241,000 | +12.1% | 138,410 | -6.5% | 0.00% | – |
| Q1 2015 | $215,000 | +61.7% | 148,065 | -6.3% | 0.00% | – |
| Q4 2014 | $133,000 | -18.4% | 158,097 | +7.7% | 0.00% | – |
| Q3 2014 | $163,000 | -43.4% | 146,811 | -6.8% | 0.00% | – |
| Q2 2014 | $288,000 | -86.6% | 157,470 | -89.0% | 0.00% | -100.0% |
| Q1 2014 | $2,149,000 | -17.6% | 1,437,770 | +0.9% | 0.00% | 0.0% |
| Q4 2013 | $2,608,000 | -38.4% | 1,424,882 | -30.6% | 0.00% | 0.0% |
| Q3 2013 | $4,231,000 | +0.3% | 2,053,915 | +21.7% | 0.00% | -50.0% |
| Q2 2013 | $4,219,000 | – | 1,687,466 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 25,243,865 | $16,913,000 | 1.18% |
| SABBY MANAGEMENT, LLC | 281,112 | $189,000 | 0.24% |
| New Leaf Venture Partners, L.L.C. | 402,118 | $271,000 | 0.07% |
| WealthTrust Axiom LLC | 134,585 | $90,000 | 0.03% |
| EXCALIBUR MANAGEMENT CORP | 51,000 | $34,000 | 0.03% |
| Caption Management, LLC | 748,200 | $503,000 | 0.02% |
| Anson Funds Management LP | 98,986 | $66,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 210,474 | $142,000 | 0.02% |
| Evercore Wealth Management, LLC | 418,414 | $282,000 | 0.01% |
| Gemmer Asset Management LLC | 1,939 | $31,000 | 0.01% |